Med Solutions Agreed to Pay $429,000 for Allegedly Violating the Civil Monetary Penalties Law by Submitting Claims for Injectable Medications that Were Not Permissible
After it self-disclosed conduct to OIG, Med Solutions, LLC (Med Solutions), New Jersey, agreed to pay $429,683.40 for allegedly violating the Civil Monetary Penalties Law. OIG alleged that Med Solutions double billed Medicare Part B for vials of Remicade, a physician-administered injectable medication used to treat autoimmune diseases. Med Solutions was permitted to administer partial vials of Remicade to avoid product waste, but was not permitted to bill for the same vial more than once.
- Date:September 1, 2016
- Provider Self-Disclosures